Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Multicenter Clinical Validation of the Molecular BD Max Enteric Viral Panel for Detection of Enteric Pathogens.

Stokes W, Simner PJ, Mortensen J, Oethinger M, Stellrecht K, Lockamy E, Lay T, Bouchy P, Pillai DR.

J Clin Microbiol. 2019 Aug 26;57(9). pii: e00306-19. doi: 10.1128/JCM.00306-19. Print 2019 Sep.

2.

Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015.

Walters MS, Grass JE, Bulens SN, Hancock EB, Phipps EC, Muleta D, Mounsey J, Kainer MA, Concannon C, Dumyati G, Bower C, Jacob J, Cassidy PM, Beldavs Z, Culbreath K, Phillips WE Jr, Hardy DJ, Vargas RL, Oethinger M, Ansari U, Stanton R, Albrecht V, Halpin AL, Karlsson M, Rasheed JK, Kallen A.

Emerg Infect Dis. 2019 Jul;25(7):1281-1288. doi: 10.3201/eid2507.181200.

3.

A randomized trial of single versus double high-level disinfection of duodenoscopes and linear echoendoscopes using standard automated reprocessing.

Bartles RL, Leggett JE, Hove S, Kashork CD, Wang L, Oethinger M, Baxter L, Brandabur JJ.

Gastrointest Endosc. 2018 Aug;88(2):306-313.e2. doi: 10.1016/j.gie.2018.02.016. Epub 2018 Feb 21.

PMID:
29476847
4.

Multisite Evaluation of the BD Max Extended Enteric Bacterial Panel for Detection of Yersinia enterocolitica, Enterotoxigenic Escherichia coli, Vibrio, and Plesiomonas shigelloides from Stool Specimens.

Simner PJ, Oethinger M, Stellrecht KA, Pillai DR, Yogev R, Leblond H, Mortensen J.

J Clin Microbiol. 2017 Nov;55(11):3258-3266. doi: 10.1128/JCM.00911-17. Epub 2017 Sep 6.

5.

Surveillance of guideline practices for duodenoscope and linear echoendoscope reprocessing in a large healthcare system.

Brandabur JJ, Leggett JE, Wang L, Bartles RL, Baxter L, Diaz GA, Grunkemeier GL, Hove S, Oethinger M.

Gastrointest Endosc. 2016 Sep;84(3):392-399.e3. doi: 10.1016/j.gie.2016.03.1480. Epub 2016 Mar 28.

PMID:
27032883
6.

Genotypic resistance testing creates new treatment challenges: two cases of oxacillin-susceptible methicillin-resistant Staphylococcus aureus.

Sharff KA, Monecke S, Slaughter S, Forrest G, Pfeiffer C, Ehricht R, Oethinger M.

J Clin Microbiol. 2012 Dec;50(12):4151-3. doi: 10.1128/JCM.01564-12. Epub 2012 Sep 19.

7.

Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia.

Frye AM, Baker CA, Rustvold DL, Heath KA, Hunt J, Leggett JE, Oethinger M.

J Clin Microbiol. 2012 Jan;50(1):127-33. doi: 10.1128/JCM.06169-11. Epub 2011 Nov 9.

8.

Diagnosing periprosthetic infection: false-positive intraoperative Gram stains.

Oethinger M, Warner DK, Schindler SA, Kobayashi H, Bauer TW.

Clin Orthop Relat Res. 2011 Apr;469(4):954-60. doi: 10.1007/s11999-010-1589-9.

9.

Distinction between intact and antibiotic-inactivated bacteria by real-time PCR after treatment with propidium monoazide.

Kobayashi H, Oethinger M, Tuohy MJ, Hall GS, Bauer TW.

J Orthop Res. 2010 Sep;28(9):1245-51. doi: 10.1002/jor.21108.

10.

Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.

Cuellar-Rodriguez J, Avery RK, Lard M, Budev M, Gordon SM, Shrestha NK, van Duin D, Oethinger M, Mawhorter SD.

Clin Infect Dis. 2009 Sep 1;49(5):710-6. doi: 10.1086/604712.

PMID:
19635026
11.

Limiting false-positive polymerase chain reaction results: detection of DNA and mRNA to differentiate viable from dead bacteria.

Kobayashi H, Oethinger M, Tuohy MJ, Procop GW, Hall GS, Bauer TW.

Diagn Microbiol Infect Dis. 2009 Aug;64(4):445-7. doi: 10.1016/j.diagmicrobio.2009.04.004.

PMID:
19631099
12.

Disseminated fusariosis in a recipient of a bone-marrow transplant.

Cuellar-Rodriguez J, Bravo LT, Oethinger M, Fraser T, Mossad SB.

Lancet Infect Dis. 2009 Aug;9(8):520. doi: 10.1016/S1473-3099(09)70112-4. No abstract available.

PMID:
19628177
13.

Unsuitable distinction between viable and dead Staphylococcus aureus and Staphylococcus epidermidis by ethidium bromide monoazide.

Kobayashi H, Oethinger M, Tuohy MJ, Hall GS, Bauer TW.

Lett Appl Microbiol. 2009 May;48(5):633-8. doi: 10.1111/j.1472-765X.2009.02585.x. Epub 2009 Mar 31.

14.

Improving clinical significance of PCR: use of propidium monoazide to distinguish viable from dead Staphylococcus aureus and Staphylococcus epidermidis.

Kobayashi H, Oethinger M, Tuohy MJ, Hall GS, Bauer TW.

J Orthop Res. 2009 Sep;27(9):1243-7. doi: 10.1002/jor.20872.

15.

Check Sample Abstracts.

Alter D, Grenache DG, Bosler DS, Karcher RE, Nichols J, Rajadhyaksha A, Camelo-Piragua S, Rauch C, Huddleston BJ, Frank EL, Sluss PM, Lewandrowski K, Eichhorn JH, Hall JE, Rahman SS, McPherson RA, Kiechle FL, Hammett-Stabler C, Pierce KA, Kloehn EA, Thomas PA, Walts AE, Madan R, Schlesinger K, Nawgiri R, Bhutani M, Kanber Y, Abati A, Atkins KA, Farrar R, Gopez EV, Jhala D, Griffin S, Jhala K, Jhala N, Bentz JS, Emerson L, Chadwick BE, Barroeta JE, Baloch ZW, Collins BT, Middleton OL, Davis GG, Haden-Pinneri K, Chu AY, Keylock JB, Ramoso R, Thoene CA, Stewart D, Pierce A, Barry M, Aljinovic N, Gardner DL, Barry M, Shields LB, Arnold J, Stewart D, Martin EL, Rakow RJ, Paddock C, Zaki SR, Prahlow JA, Stewart D, Shields LB, Rolf CM, Falzon AL, Hudacki R, Mazzella FM, Bethel M, Zarrin-Khameh N, Gresik MV, Gill R, Karlon W, Etzell J, Deftos M, Karlon WJ, Etzell JE, Wang E, Lu CM, Manion E, Rosenthal N, Wang E, Lu CM, Tang P, Petric M, Schade AE, Hall GS, Oethinger M, Hall G, Picton AR, Hoang L, Imperial MR, Kibsey P, Waites K, Duffy L, Hall GS, Salangsang JA, Bravo LT, Oethinger MD, Veras E, Silva E, Vicens J, Silva E, Keylock J, Hempel J, Rushing E, Posligua LE, Deavers MT, Nash JW, Basturk O, Perle MA, Greco A, Lee P, Maru D, Weydert JA, Stevens TM, Brownlee NA, Kemper AE, Williams HJ, Oliverio BJ, Al-Agha OM, Eskue KL, Newlands SD, Eltorky MA, Puri PK, Royer MC, Rush WL, Tavora F, Galvin JR, Franks TJ, Carter JE, Kahn AG, Lozada Muñoz LR, Houghton D, Land KJ, Nester T, Gildea J, Lefkowitz J, Lacount RA, Thompson HW, Refaai MA, Quillen K, Lopez AO, Goldfinger D, Muram T, Thompson H.

Am J Clin Pathol. 2009 Feb;131(2):286-299.

PMID:
19176368
16.

Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.

Endimiani A, Hujer AM, Perez F, Bethel CR, Hujer KM, Kroeger J, Oethinger M, Paterson DL, Adams MD, Jacobs MR, Diekema DJ, Hall GS, Jenkins SG, Rice LB, Tenover FC, Bonomo RA.

J Antimicrob Chemother. 2009 Mar;63(3):427-37. doi: 10.1093/jac/dkn547. Epub 2009 Jan 20.

17.

A marble under the skin.

Magauran CE, Oethinger M, Armstrong WS.

Clin Infect Dis. 2008 Dec 15;47(12):1579, 1600-1. doi: 10.1086/593308. No abstract available.

PMID:
19025365
18.

Improved detection of biofilm-formative bacteria by vortexing and sonication: a pilot study.

Kobayashi H, Oethinger M, Tuohy MJ, Procop GW, Bauer TW.

Clin Orthop Relat Res. 2009 May;467(5):1360-4. doi: 10.1007/s11999-008-0609-5. Epub 2008 Nov 7.

20.

Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.

Kern WV, Klose K, Jellen-Ritter AS, Oethinger M, Bohnert J, Kern P, Reuter S, von Baum H, Marre R.

Eur J Clin Microbiol Infect Dis. 2005 Feb;24(2):111-8.

PMID:
15714332
21.

Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli.

Kern WV, Oethinger M, Jellen-Ritter AS, Levy SB.

Antimicrob Agents Chemother. 2000 Apr;44(4):814-20.

22.
23.

Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: clonal analysis.

Oethinger M, Jellen-Ritter AS, Conrad S, Marre R, Kern WV.

Infection. 1998 Nov-Dec;26(6):379-84.

PMID:
9861564
24.
25.

Triclosan targets lipid synthesis.

McMurry LM, Oethinger M, Levy SB.

Nature. 1998 Aug 6;394(6693):531-2. No abstract available.

PMID:
9707111
26.

Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli.

Oethinger M, Podglajen I, Kern WV, Levy SB.

Antimicrob Agents Chemother. 1998 Aug;42(8):2089-94.

27.

Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli.

Oethinger M, Kern WV, Goldman JD, Levy SB.

J Antimicrob Chemother. 1998 Jan;41(1):111-4.

PMID:
9511045
28.

Autotransfusion--bacterial contamination during hip arthroplasty and efficacy of cefuroxime prophylaxis. A randomized controlled study of 40 patients.

Wollinsky KH, Oethinger M, Büchele M, Kluger P, Puhl W, Mehrkens HH.

Acta Orthop Scand. 1997 Jun;68(3):225-30.

PMID:
9246981
29.

gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.

Conrad S, Oethinger M, Kaifel K, Klotz G, Marre R, Kern WV.

J Antimicrob Chemother. 1996 Sep;38(3):443-55.

PMID:
8889719
30.

Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers.

Oethinger M, Conrad S, Kaifel K, Cometta A, Bille J, Klotz G, Glauser MP, Marre R, Kern WV.

Antimicrob Agents Chemother. 1996 Feb;40(2):387-92.

31.

Influence of hemodilution on cefuroxime levels and bacterial contamination of intra- and postoperative processed wound blood during hip replacement.

Wollinsky KH, Büchele M, Oethinger M, Kluger P, Mehrkens HH, Marre R, Puhl W.

Beitr Infusionsther Transfusionsmed. 1996;33:191-5.

PMID:
8865946
32.

In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms.

Lauterwein M, Oethinger M, Belsner K, Peters T, Marre R.

Antimicrob Agents Chemother. 1995 Nov;39(11):2541-3.

33.

Teicoplanin: 10 years of clinical experience.

Trautmann M, Wiedeck H, Ruhnke M, Oethinger M, Marre R.

Infection. 1994 Nov-Dec;22(6):430-6. Review.

PMID:
7698846
34.

A fatal infection with Alternaria alternata and Aspergillus terreus in a child with agranulocytosis of unknown origin.

Neumeister B, Hartmann W, Oethinger M, Heymer B, Marre R.

Mycoses. 1994 Jun-Jul;37(5-6):181-5.

PMID:
7898514
35.

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.

Kern WV, Andriof E, Oethinger M, Kern P, Hacker J, Marre R.

Antimicrob Agents Chemother. 1994 Apr;38(4):681-7.

36.

Ochrobactrum anthropi bacteremia: report of four cases and short review.

Kern WV, Oethinger M, Kaufhold A, Rozdzinski E, Marre R.

Infection. 1993 Sep-Oct;21(5):306-10. Review.

PMID:
8300247
37.

Influence of acute myocardial infarction and rt-PA therapy on circulating fibrinogen.

Seifried E, Oethinger M, Tanswell P, Hoegee-de Nobel E, Nieuwenhuizen W.

Thromb Haemost. 1993 Apr 1;69(4):321-7.

PMID:
8497843
38.

Studies on the functionality of fibrinogen during rt-PA therapy: results of three different methods of fibrinogen determination.

Seifried E, Oethinger M, Tanswell P, Hoegee-de Nobel H, Nieuwenhuizen W.

Blood Coagul Fibrinolysis. 1992 Feb;3(1):81-7.

PMID:
1623123
39.

In vitro effects of urokinase--prevention by different inhibitors.

Oethinger MD, Seifried E.

Thromb Haemost. 1990 Nov 30;64(3):402-6.

PMID:
1710833
40.

Thyroid growth stimulating activity in highly purified IgG-fractions of patients with nonimmune thyroid diseases.

Oethinger MD, Wenzel BE, Scriba PC.

J Endocrinol Invest. 1989 Oct;12(9):631-42.

PMID:
2573626

Supplemental Content

Loading ...
Support Center